speb/financial-data huggingface dataset:
MSEX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 20838000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 20838000.00
MSEX balance_sheet (annual, 2025-12-31) — Gross PPE: 1429639000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1429639000.00
MSEX income_statement (annual, 2025-12-31) — Gross Profit: 103403000.00
MSEX income_statement (quarterly, 2025-12-31) — Gross Profit: 23601000.00
MSEX income_statement (annual, 2025-12-31) — Interest Expense: 14295000.00
MSEX income_statement (quarterly, 2025-12-31) — Interest Expense: 3760000.00
MSEX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 14295000.00
MSEX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3760000.00
MSEX balance_sheet (annual, 2025-12-31) — Interest Payable: 3311000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Interest Payable: 3311000.00
MSEX balance_sheet (annual, 2025-12-31) — Inventory: 7549000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Inventory: 7549000.00
MSEX balance_sheet (annual, 2025-12-31) — Invested Capital: 909005000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 909005000.00
MSEX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -100961000.00
MSEX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -24712000.00
MSEX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 30454000.00
MSEX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 9173000.00
MSEX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 33615000.00
MSEX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 30012000.00
MSEX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1838000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1838000.00
MSEX balance_sheet (annual, 2025-12-31) — Long Term Debt: 378874000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 378874000.00
MSEX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 380712000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 380712000.00
MSEX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 33615000.00
MSEX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 30012000.00
MSEX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -7317000.00
MSEX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -987000.00
MSEX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 30454000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 9173000.00
MSEX balance_sheet (annual, 2025-12-31) — Net Debt: 412174000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Net Debt: 412174000.00
MSEX income_statement (annual, 2025-12-31) — Net Income: 42822000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income: 8605000.00
MSEX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 42746000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 8588000.00
MSEX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 42822000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 8605000.00
MSEX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 42822000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 8605000.00
MSEX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 42822000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 8605000.00
MSEX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 42822000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 8605000.00
MSEX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 42822000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 8605000.00
MSEX income_statement (annual, 2025-12-31) — Net Interest Income: -14295000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Interest Income: -3760000.00
MSEX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 31548000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2275000.00
MSEX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 26298000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 29025000.00
MSEX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -14295000.00
MSEX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3760000.00
MSEX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 1612000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 852000.00
MSEX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4607000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
MSEX balance_sheet (annual, 2025-12-31) — Net PPE: 1149207000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Net PPE: 1149207000.00
MSEX cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 5250000.00
MSEX cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -26750000.00
MSEX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 495374000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 495374000.00
MSEX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 135994000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 135994000.00
MSEX balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 25519000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 25519000.00
MSEX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 110475000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 110475000.00
MSEX income_statement (annual, 2025-12-31) — Normalized EBITDA: 92815000.00
MSEX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 21292000.00
MSEX income_statement (annual, 2025-12-31) — Normalized Income: 41367725.58
MSEX income_statement (quarterly, 2025-12-31) — Normalized Income: 8239801.06
MSEX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 62596000.00
MSEX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 18462000.00
MSEX income_statement (annual, 2025-12-31) — Operating Income: 54376000.00
MSEX income_statement (quarterly, 2025-12-31) — Operating Income: 11205000.00
MSEX income_statement (annual, 2025-12-31) — Operating Revenue: 194694000.00
MSEX income_statement (quarterly, 2025-12-31) — Operating Revenue: 46979000.00
MSEX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 18521000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 18521000.00
MSEX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 7850000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 7850000.00
MSEX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 6569000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 6569000.00
MSEX income_statement (annual, 2025-12-31) — Other Income Expense: 7562000.00
MSEX income_statement (quarterly, 2025-12-31) — Other Income Expense: 1980000.00
MSEX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1273000.00
MSEX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -404000.00
MSEX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 20180000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 20180000.00
MSEX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 191425000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 191425000.00
MSEX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 5944000.00
MSEX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1580000.00
MSEX balance_sheet (annual, 2025-12-31) — Other Properties: 7300000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Other Properties: 7300000.00
MSEX income_statement (annual, 2025-12-31) — Other Special Charges: -1618000.00
MSEX income_statement (quarterly, 2025-12-31) — Other Special Charges: -400000.00
MSEX income_statement (annual, 2025-12-31) — Other Taxes: 21914000.00
MSEX income_statement (quarterly, 2025-12-31) — Other Taxes: 5454000.00
MSEX balance_sheet (annual, 2025-12-31) — Payables: 47318000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Payables: 47318000.00
MSEX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 50629000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 50629000.00
MSEX balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 13000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 13000.00
MSEX balance_sheet (annual, 2025-12-31) — Preferred Stock: 1343000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 1343000.00
MSEX cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -76000.00
MSEX cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -17000.00
MSEX income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 76000.00
MSEX income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 17000.00
MSEX balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 1343000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 1343000.00
MSEX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2843000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2843000.00
MSEX income_statement (annual, 2025-12-31) — Pretax Income: 47643000.00
MSEX income_statement (quarterly, 2025-12-31) — Pretax Income: 9425000.00
MSEX balance_sheet (annual, 2025-12-31) — Receivables: 28574000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Receivables: 28574000.00
MSEX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 85909000.00
MSEX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 21813000.00
MSEX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 32495000.00
MSEX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 8507000.00
MSEX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -7317000.00
MSEX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -987000.00
MSEX balance_sheet (annual, 2025-12-31) — Retained Earnings: 214883000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 214883000.00
MSEX balance_sheet (annual, 2025-12-31) — Share Issued: 18521000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Share Issued: 18521000.00
MSEX income_statement (annual, 2025-12-31) — Special Income Charges: 1618000.00
MSEX income_statement (quarterly, 2025-12-31) — Special Income Charges: 400000.00
MSEX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1237000.00
MSEX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 118000.00
MSEX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 495374000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 495374000.00
MSEX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 494031000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 494031000.00
MSEX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 163725.58
MSEX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 34801.06
MSEX income_statement (annual, 2025-12-31) — Tax Provision: 4821000.00
MSEX income_statement (quarterly, 2025-12-31) — Tax Provision: 820000.00
MSEX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.10
MSEX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.09
MSEX balance_sheet (annual, 2025-12-31) — Total Assets: 1365737000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Assets: 1365737000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Capitalization: 874248000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 874248000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Debt: 416812000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Debt: 416812000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 495374000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 495374000.00
MSEX income_statement (annual, 2025-12-31) — Total Expenses: 140318000.00
MSEX income_statement (quarterly, 2025-12-31) — Total Expenses: 35774000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 870363000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 870363000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1323999000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1323999000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 776568000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 776568000.00
MSEX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 54376000.00
MSEX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 11205000.00
MSEX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 15992000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 15992000.00
MSEX income_statement (annual, 2025-12-31) — Total Unusual Items: 1618000.00
MSEX income_statement (quarterly, 2025-12-31) — Total Unusual Items: 400000.00
MSEX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1618000.00
MSEX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 400000.00
MSEX balance_sheet (annual, 2025-12-31) — Working Capital: -52029000.00
MSEX balance_sheet (quarterly, 2025-12-31) — Working Capital: -52029000.00
MSEX income_statement (quarterly, 2026-03-31) — +Operating Expense: 12600000.00
MSEX income_statement (quarterly, 2026-03-31) — +Total Revenue: 48714000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 29496000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18690000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -276456000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1873000.00
MSEX income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 4000.00
MSEX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 18545000.00
MSEX income_statement (quarterly, 2026-03-31) — Basic EPS: 0.57
MSEX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4475000.00
MSEX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -20641000.00
MSEX cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -20641000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1653000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 283586000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2040000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2040000.00
MSEX cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -6685000.00
MSEX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 8150000.00
MSEX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -20641000.00
MSEX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 11731000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -2132000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -20000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 6124000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Interest Payable: -20000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -546000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -4906000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Payable: 3992000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3972000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -3143000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -463000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 6124000.00
MSEX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5086000.00
MSEX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 523000.00
MSEX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -760000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Common Stock: 282243000.00
MSEX cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -6667000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 501046000.00
MSEX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 2819000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 49593000.00
MSEX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 23012000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 3291000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Assets: 46827000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Debt: 54666000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 54666000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 467000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 467000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 119655000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 47000000.00
MSEX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -2072000.00
MSEX cash_flow (quarterly, 2026-03-31) — Deferred Tax: -2072000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 45041000.00
MSEX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 8187000.00
MSEX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 7036000.00
MSEX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 8187000.00
MSEX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 7036000.00
MSEX income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 7036000.00
MSEX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 18575000.00
MSEX income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.57
MSEX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 10591000.00
MSEX income_statement (quarterly, 2026-03-31) — EBIT: 15104000.00
MSEX income_statement (quarterly, 2026-03-31) — EBITDA: 23291000.00
MSEX cash_flow (quarterly, 2026-03-31) — End Cash Position: 3715000.00
MSEX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 8150000.00
MSEX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -8910000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 20563000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1447051000.00
MSEX income_statement (quarterly, 2026-03-31) — Gross Profit: 25702000.00
MSEX income_statement (quarterly, 2026-03-31) — Interest Expense: 3214000.00
MSEX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3214000.00
MSEX cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 3194000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Interest Payable: 3291000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Inventory: 8095000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 927388000.00
MSEX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -20641000.00
MSEX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2819000.00
MSEX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1496000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1653000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 371676000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 373329000.00
MSEX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1496000.00
MSEX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -8904000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2819000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Net Debt: 424302000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income: 10605000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 10587000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 10605000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10605000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 10605000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 10605000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 10605000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Interest Income: -3214000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 11342000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -7408000.00
MSEX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3214000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 674000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Net PPE: 1170595000.00
MSEX cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 18750000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 502389000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 137115000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 25963000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 111152000.00
MSEX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 22658000.00
MSEX income_statement (quarterly, 2026-03-31) — Normalized Income: 10040364.00
MSEX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 11731000.00
MSEX income_statement (quarterly, 2026-03-31) — Operating Income: 13102000.00
MSEX income_statement (quarterly, 2026-03-31) — Operating Revenue: 48714000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18577000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1669000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 7666000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 9619000.00
MSEX income_statement (quarterly, 2026-03-31) — Other Income Expense: 2002000.00
MSEX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -304000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 20574000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 192185000.00
MSEX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 1369000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Other Properties: 1830000.00
MSEX income_statement (quarterly, 2026-03-31) — Other Special Charges: -633000.00
MSEX income_statement (quarterly, 2026-03-31) — Other Taxes: 5564000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Payables: 51612000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 54903000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 13000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 1343000.00
MSEX cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -18000.00
MSEX income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 18000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 1343000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 5986000.00
MSEX income_statement (quarterly, 2026-03-31) — Pretax Income: 11890000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Receivables: 29037000.00
MSEX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 21861000.00
MSEX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 8187000.00
MSEX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -8904000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 218803000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Share Issued: 18577000.00
MSEX income_statement (quarterly, 2026-03-31) — Special Income Charges: 633000.00
MSEX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 401000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 502389000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 501046000.00
MSEX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 68364.00
MSEX income_statement (quarterly, 2026-03-31) — Tax Provision: 1285000.00
MSEX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.11
MSEX balance_sheet (quarterly, 2026-03-31) — Total Assets: 1386038000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 874065000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Debt: 427995000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 502389000.00
MSEX income_statement (quarterly, 2026-03-31) — Total Expenses: 35612000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 883649000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1339211000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 763994000.00
MSEX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 13102000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 22116000.00
MSEX income_statement (quarterly, 2026-03-31) — Total Unusual Items: 633000.00
MSEX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 633000.00
MSEX balance_sheet (quarterly, 2026-03-31) — Working Capital: -72828000.00
MSF.DE cash_flow (annual, 2021-06-30) — Change In Income Tax Payable: -2309000000.00
MSF.DE cash_flow (annual, 2021-06-30) — Change In Tax Payable: -2309000000.00
MSF.DE balance_sheet (annual, 2021-06-30) — Finished Goods: 1367000000.00
MSF.DE balance_sheet (annual, 2021-06-30) — Raw Materials: 1190000000.00
MSF.DE balance_sheet (annual, 2021-06-30) — Work In Process: 79000000.00
MSF.DE income_statement (annual, 2022-06-30) — +Operating Expense: 52237000000.00
MSF.DE income_statement (annual, 2022-06-30) — +Total Revenue: 198270000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Accounts Payable: 19000000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Accounts Receivable: 44261000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -59660000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -633000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Asset Impairment Charge: 101000000.00
MSF.DE income_statement (annual, 2022-06-30) — Basic Average Shares: 7496000000.00
MSF.DE income_statement (annual, 2022-06-30) — Basic EPS: 9.70
MSF.DE cash_flow (annual, 2022-06-30) — Beginning Cash Position: 14224000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 55014000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Capital Expenditure: -23886000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 11489000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Capital Stock: 86939000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 13931000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 104749000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -18135000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Cash Equivalents: 5673000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Cash Financial: 8258000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -58876000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -30311000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: 89035000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Account Payable: 2943000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Income Tax Payable: 696000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Inventory: -1123000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Other Current Assets: -3514000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: 3169000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Other Working Capital: 5805000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Payable: 2943000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 2943000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Receivables: -6834000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Tax Payable: 696000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Change In Working Capital: 446000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Changes In Account Receivables: -6834000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Changes In Cash: -152000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Common Stock: 86939000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -18135000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Common Stock Equity: 166542000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Common Stock Issuance: 1841000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Common Stock Payments: -32696000000.00
MSF.DE income_statement (annual, 2022-06-30) — Cost Of Revenue: 62650000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Assets: 169684000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Debt: 2749000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 2749000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 45538000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 45538000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Current Liabilities: 95082000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Deferred Income Tax: -5702000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Deferred Tax: -5702000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Depreciation: 14460000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 14460000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 14460000000.00
MSF.DE income_statement (annual, 2022-06-30) — Diluted Average Shares: 7540000000.00
MSF.DE income_statement (annual, 2022-06-30) — Diluted EPS: 9.65
MSF.DE income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — EBIT: 85779000000.00
MSF.DE income_statement (annual, 2022-06-30) — EBITDA: 100239000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: -141000000.00
MSF.DE cash_flow (annual, 2022-06-30) — End Cash Position: 13931000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Financial Assets: 0.00
MSF.DE cash_flow (annual, 2022-06-30) — Financing Cash Flow: -58876000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Finished Goods: 2516000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Free Cash Flow: 65149000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Gain Loss On Investment Securities: -1000000.00
MSF.DE income_statement (annual, 2022-06-30) — Gain On Sale Of Security: 435000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: -4678000000.00
MSF.DE income_statement (annual, 2022-06-30) — General And Administrative Expense: 5900000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Goodwill: 67524000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 78822000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 44894000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Gross PPE: 147206000000.00
MSF.DE income_statement (annual, 2022-06-30) — Gross Profit: 135620000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Hedging Assets Current: 8000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Income Tax Payable: 4067000000.00
MSF.DE income_statement (annual, 2022-06-30) — Interest Expense: 2063000000.00
MSF.DE income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 2063000000.00
MSF.DE income_statement (annual, 2022-06-30) — Interest Income: 2094000000.00
MSF.DE income_statement (annual, 2022-06-30) — Interest Income Non Operating: 2094000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Inventory: 3742000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Invested Capital: 216323000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Investing Cash Flow: -30311000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Investmentin Financial Assets: 0.00
MSF.DE balance_sheet (annual, 2022-06-30) — Investments And Advances: 6891000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 1841000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Issuance Of Debt: 0.00
MSF.DE balance_sheet (annual, 2022-06-30) — Land And Improvements: 4734000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Leases: 7819000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 11489000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Long Term Debt: 47032000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 58521000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 0.00
MSF.DE cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -9023000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 6891000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 66491000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: -22038000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: -30855000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Net Debt: 35850000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 72738000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 72738000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Interest Income: 31000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 18438000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -9023000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -9023000000.00
MSF.DE income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: 31000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -863000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -2825000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Net PPE: 87546000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -23886000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Net Short Term Debt Issuance: 0.00
MSF.DE balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 87720000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Non Current Deferred Liabilities: 3100000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Non Current Deferred Revenue: 2870000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Liabilities: 230000000.00
MSF.DE income_statement (annual, 2022-06-30) — Normalized EBITDA: 99905000000.00
MSF.DE income_statement (annual, 2022-06-30) — Normalized Income: 72447754000.00
MSF.DE cash_flow (annual, 2022-06-30) — Operating Cash Flow: 89035000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Operating Gains Losses: -1000000.00
MSF.DE income_statement (annual, 2022-06-30) — Operating Income: 83383000000.00
MSF.DE income_statement (annual, 2022-06-30) — Operating Revenue: 198270000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 7464000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Current Assets: 16924000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 13067000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: -4678000000.00
MSF.DE income_statement (annual, 2022-06-30) — Other Gand A: 5900000000.00
MSF.DE income_statement (annual, 2022-06-30) — Other Income Expense: 302000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 11298000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 21897000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 15526000000.00
MSF.DE income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: -32000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Properties: 13148000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 90818000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Payables: 23067000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 23067000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 10661000000.00
MSF.DE income_statement (annual, 2022-06-30) — Pretax Income: 83716000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Properties: 0.00
MSF.DE cash_flow (annual, 2022-06-30) — Purchase Of Business: -22038000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Purchase Of Investment: -26456000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Purchase Of PPE: -23886000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Raw Materials: 1144000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Receivables: 44261000000.00
MSF.DE income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 62650000000.00
MSF.DE income_statement (annual, 2022-06-30) — Reconciled Depreciation: 14460000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Repayment Of Debt: -9023000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -32696000000.00
MSF.DE income_statement (annual, 2022-06-30) — Research And Development: 24512000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Retained Earnings: 84281000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Sale Of Investment: 44894000000.00
MSF.DE income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 21825000000.00
MSF.DE income_statement (annual, 2022-06-30) — Selling General And Administration: 27725000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Share Issued: 7464000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Short Term Debt Issuance: 0.00
MSF.DE income_statement (annual, 2022-06-30) — Special Income Charges: -101000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Stock Based Compensation: 7502000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Stockholders Equity: 166542000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Tangible Book Value: 87720000000.00
MSF.DE income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 43754000.00
MSF.DE income_statement (annual, 2022-06-30) — Tax Provision: 10978000000.00
MSF.DE income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.13
MSF.DE balance_sheet (annual, 2022-06-30) — Total Assets: 364840000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Capitalization: 213574000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Debt: 61270000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 166542000000.00
MSF.DE income_statement (annual, 2022-06-30) — Total Expenses: 114887000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 198298000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 195156000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 103216000000.00
MSF.DE income_statement (annual, 2022-06-30) — Total Operating Income As Reported: 83383000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Total Tax Payable: 4067000000.00
MSF.DE income_statement (annual, 2022-06-30) — Total Unusual Items: 334000000.00
MSF.DE income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: 334000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Tradeand Other Payables Non Current: 26069000000.00
MSF.DE cash_flow (annual, 2022-06-30) — Unrealized Gain Loss On Investment Securities: -509000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Work In Process: 82000000.00
MSF.DE balance_sheet (annual, 2022-06-30) — Working Capital: 74602000000.00
MSF.DE income_statement (annual, 2022-06-30) — Write Off: 101000000.00
MSF.DE income_statement (annual, 2023-06-30) — +Operating Expense: 57529000000.00
MSF.DE income_statement (annual, 2023-06-30) — +Total Revenue: 211915000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Accounts Payable: 18095000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Accounts Receivable: 48688000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -68251000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -650000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Asset Impairment Charge: 30000000.00
MSF.DE income_statement (annual, 2023-06-30) — Basic Average Shares: 7446000000.00
MSF.DE income_statement (annual, 2023-06-30) — Basic EPS: 9.72
MSF.DE cash_flow (annual, 2023-06-30) — Beginning Cash Position: 13931000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Buildings And Improvements: 68465000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Capital Expenditure: -28107000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 12728000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Capital Stock: 93718000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 34704000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 111256000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Cash Dividends Paid: -19800000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Cash Equivalents: 26226000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Cash Financial: 8478000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -43935000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -22680000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: 87582000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Account Payable: -2721000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Income Tax Payable: -358000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Inventory: 1242000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Other Current Assets: -4824000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: 2825000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Other Working Capital: 5177000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Payable: -2721000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: -2721000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Receivables: -4087000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Tax Payable: -358000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Change In Working Capital: -2388000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Changes In Account Receivables: -4087000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Changes In Cash: 20967000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Commercial Paper: 0.00
MSF.DE balance_sheet (annual, 2023-06-30) — Common Stock: 93718000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Common Stock Dividend Paid: -19800000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Common Stock Equity: 206223000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Common Stock Issuance: 1866000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Common Stock Payments: -22245000000.00
MSF.DE income_statement (annual, 2023-06-30) — Cost Of Revenue: 65863000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Assets: 184257000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Debt: 5247000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 5247000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 50901000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 50901000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Current Liabilities: 104149000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Deferred Income Tax: -6059000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Deferred Tax: -6059000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Depreciation: 13861000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 13861000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 13861000000.00
MSF.DE income_statement (annual, 2023-06-30) — Diluted Average Shares: 7472000000.00
MSF.DE income_statement (annual, 2023-06-30) — Diluted EPS: 9.68
MSF.DE income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 72361000000.00
MSF.DE income_statement (annual, 2023-06-30) — EBIT: 91279000000.00
MSF.DE income_statement (annual, 2023-06-30) — EBITDA: 105140000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: -194000000.00
MSF.DE cash_flow (annual, 2023-06-30) — End Cash Position: 34704000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Financial Assets: 0.00
MSF.DE cash_flow (annual, 2023-06-30) — Financing Cash Flow: -43935000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Finished Goods: 1768000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Free Cash Flow: 59475000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Gain Loss On Investment Securities: 469000000.00
MSF.DE income_statement (annual, 2023-06-30) — Gain On Sale Of Security: 15000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: -6343000000.00
MSF.DE income_statement (annual, 2023-06-30) — General And Administrative Expense: 7575000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Goodwill: 67886000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 77252000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 49338000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Gross PPE: 178238000000.00
MSF.DE income_statement (annual, 2023-06-30) — Gross Profit: 146052000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Hedging Assets Current: 6000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Income Tax Payable: 4152000000.00
MSF.DE income_statement (annual, 2023-06-30) — Interest Expense: 1968000000.00
MSF.DE income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 1968000000.00
MSF.DE income_statement (annual, 2023-06-30) — Interest Income: 2994000000.00
MSF.DE income_statement (annual, 2023-06-30) — Interest Income Non Operating: 2994000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Inventory: 2500000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Invested Capital: 253460000000.00
MSF.DE cash_flow (annual, 2023-06-30) — Investing Cash Flow: -22680000000.00
MSF.DE balance_sheet (annual, 2023-06-30) — Investmentin Financial Assets: 0.00
MSF.DE balance_sheet (annual, 2023-06-30) — Investments And Advances: 9879000000.00